Van der Moeren, N.; Selhorst, P.; Ha, M.; Heireman, L.; Van Gaal, P.-J.; Breems, D.; Meysman, P.; Laukens, K.; Verstrepen, W.; Van Gasse, N.;
et al. Viral Evolution and Immunology of SARS-CoV-2 in a Persistent Infection after Treatment with Rituximab. Viruses 2022, 14, 752.
https://doi.org/10.3390/v14040752
AMA Style
Van der Moeren N, Selhorst P, Ha M, Heireman L, Van Gaal P-J, Breems D, Meysman P, Laukens K, Verstrepen W, Van Gasse N,
et al. Viral Evolution and Immunology of SARS-CoV-2 in a Persistent Infection after Treatment with Rituximab. Viruses. 2022; 14(4):752.
https://doi.org/10.3390/v14040752
Chicago/Turabian Style
Van der Moeren, Nathalie, Philippe Selhorst, My Ha, Laura Heireman, Pieter-Jan Van Gaal, Dimitri Breems, Pieter Meysman, Kris Laukens, Walter Verstrepen, Natasja Van Gasse,
and et al. 2022. "Viral Evolution and Immunology of SARS-CoV-2 in a Persistent Infection after Treatment with Rituximab" Viruses 14, no. 4: 752.
https://doi.org/10.3390/v14040752
APA Style
Van der Moeren, N., Selhorst, P., Ha, M., Heireman, L., Van Gaal, P.-J., Breems, D., Meysman, P., Laukens, K., Verstrepen, W., Van Gasse, N., Ogunjimi, B., Arien, K. K., & Naesens, R.
(2022). Viral Evolution and Immunology of SARS-CoV-2 in a Persistent Infection after Treatment with Rituximab. Viruses, 14(4), 752.
https://doi.org/10.3390/v14040752